Correlation Between Enlivex Therapeutics and Lineage Cell
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Lineage Cell Therapeutics, you can compare the effects of market volatilities on Enlivex Therapeutics and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Lineage Cell.
Diversification Opportunities for Enlivex Therapeutics and Lineage Cell
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enlivex and Lineage is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Lineage Cell go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Lineage Cell
Assuming the 90 days trading horizon Enlivex Therapeutics is expected to under-perform the Lineage Cell. In addition to that, Enlivex Therapeutics is 1.29 times more volatile than Lineage Cell Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 47,190 in Lineage Cell Therapeutics on November 2, 2024 and sell it today you would lose (24,890) from holding Lineage Cell Therapeutics or give up 52.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Lineage Cell Therapeutics
Performance |
| Timeline |
| Enlivex Therapeutics |
| Lineage Cell Therapeutics |
Enlivex Therapeutics and Lineage Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Lineage Cell
The main advantage of trading using opposite Enlivex Therapeutics and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.The idea behind Enlivex Therapeutics and Lineage Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Lineage Cell vs. ICL Israel Chemicals | Lineage Cell vs. Libra Insurance | Lineage Cell vs. TAT Technologies | Lineage Cell vs. Meitav Trade Inv |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |